Light Activation of Retinal Insulin Receptor Signaling
Light Activation of Retinal Insulin Receptor Signaling
批准号:
7442117
负责人:
Raju VS Rajala
金额:
$31.37万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-01 至 2010-06-30
关键词:
AddressArrestinArrestinsBiochemicalBiologicalBiologyCell SurvivalCytoskeletonDataDegenerative DisorderFutureGeneticGoalsInsulin ReceptorIrisKnock-outKnockout MiceLightLipidsLocalizedMaintenanceMembraneMolecularMolecular GeneticsMusNeuronsNumbersOpsinPathway interactionsPhosphatidylinositolsPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhotobleachingPhotoreceptorsPlasmaProtein DephosphorylationProtein Tyrosine PhosphataseProteinsRanaReceptor ActivationReceptor SignalingRegulationResearch PersonnelRetinaRetinalRetinal DegenerationRhodopsinRod Outer SegmentsRoleSignal PathwaySignal TransductionStructureTestingTherapeutic InterventionTransgenic OrganismsTyrosineTyrosine Phosphorylationdesignhuman IRS2 proteinin vivoinhibitor/antagonistinsightinsulin secretionlight effectsnovelpreventprogramspromoterretinal rods
中文摘要
描述(由申请人提供):长期目标是了解胰岛素受体(IR)在视网膜中的作用,并阐明它们产生的细胞内信号通路。本提案的总体目标是获得对光感受器功能控制的新认识。具体目的是研究视网膜IR在光感受器结构和功能调节中的作用。我们的新发现是,光刺激体内IR b亚基的酪氨酸磷酸化,进而激活磷酸肌肽3-激酶,这是一种细胞存活因子。光效应局限于光感受器神经元,与胰岛素分泌无关。我们已经确定Grb14是IR的上游调节剂(IR)需要光漂白视紫质来进行膜靶向。此外,Grb14是蛋白酪氨酸磷酸酶PTP1 b的抑制剂,其特异性地使IR去磷酸化。这些观察结果导致了一种假设,即光信号启动Grb14定位到光感受器外段膜,从而抑制PTP1 b,从而保护IR磷酸化。因此,光诱导的IR激活促进了光感受器的存活和维持。新发现的途径可能对光感受器信号传导的其他方面有影响。以下具体目标旨在验证我们的中心假设,即光诱导的IR激活对正常光感受器的存活和维持很重要。目的1是确定光感受器细胞中的IR是否是光激活生存途径所必需的。目的2是确定Grb14和PTP1b调控IR的机制。目的3是确定Grb14的结构域,这些结构域是杆状光感受器细胞中光依赖性易位所必需的。我们将利用遗传、分子和生化方法的结合来解决该途径的新生物学问题。总之,这些研究将为光对光感受器结构和功能的分子调控提供新的见解。所获得的信息将对理解新发现的杆状光感受器通路的新生物学具有重要意义。这些研究结果将有助于更好地了解视网膜变性的机制,并指导未来治疗干预的目标。生物学意义延伸到一些视网膜退行性疾病的病因和治疗。
英文摘要
DESCRIPTION (provided by applicant): The long term goal is to understand the role of insulin receptors (IR) in the retina and elucidate the intracellular signaling pathways they generate. The overall goal of this proposal is to gain new understanding of the control of photoreceptor function. The specific objective is to investigate the role of the retinal IR in regulation of photoreceptor structure and function. We made the novel finding that light stimulates tyrosine phosphorylation of the b-subunit of IR in vivo, and, in turn, activate phosphoinositide 3-kinase, a cell survival factor. The light effect is localized to photoreceptor neurons and is independent of insulin secretion. We have identified Grb14 an upstream regulator of IR (IR) requires photobleaching of rhodopsin for membrane targeting. Further Grb14 is an inhibitor of protein tyrosine phosphatase PTP1 b which specially dephosphorylates the IR. These observations led to the hypothesis that a light signal initiates the localization of Grb14 to photoreceptor outer segment membranes which leads to the inhibition of PTP1 b resulting in the protection of IR phosphorylation. Thus, the light-induced IR activation promotes photoreceptor survival and maintenance. The newly discovered pathway may have implications in other aspects of photoreceptor signaling. The following specific aims are designed to test our central hypothesis that light-induced activation of IR is important for normal photoreceptor survival and maintenance. Aim 1 is to determine whether the IR in photoreceptor cells is necessary for light activation of survival pathways. Aim 2 is to determine the mechanism of regulation of the IR by Grb14 and PTP1b. Aim 3 is to determine the domains of Grb14 that are required for light-dependent translocation in rod photoreceptor cells. We will utilize a combination of genetic, molecular and biochemical approaches to address the novel biology of the pathway. Together, these studies will provide novel insights into the molecular regulation of photoreceptor structure and function by light. The information gained will be important for understanding the novel biology of the newly discovered pathway in rod photoreceptor. Results of these studies will help better understanding the mechanism of retinal degenerations and guide targets for future therapeutic intervention. The biological implications extend to the cause and treatment of a number of retinal degenerative diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
-
批准号:10717825
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2023
-
负责人:Raju VS Rajala
-
依托单位:
Neuroprotection Mechanism for Photoreceptors
-
批准号:10428577
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2019
-
负责人:Raju VS Rajala
-
依托单位:
Neuroprotection Mechanism for Photoreceptors
-
批准号:10183260
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2019
-
负责人:Raju VS Rajala
-
依托单位:
Neuroprotection Mechanism for Photoreceptors
-
批准号:10006824
-
项目类别:
-
资助金额:$42.27万
-
财政年份:2019
-
负责人:Raju VS Rajala
-
依托单位:
Mechanistic studies on obesity-deteriorated glucose and lipid metabolisms
-
批准号:8874215
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2013
-
负责人:Raju VS Rajala
-
依托单位:
P30 Center Core Grant for Vision Research
-
批准号:10272005
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2011
-
负责人:Raju VS Rajala
-
依托单位:
P30 Center Core Grant for Vision Research
-
批准号:10477417
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2011
-
负责人:Raju VS Rajala
-
依托单位:
P30 Center Core Grant for Vision Research
-
批准号:10696213
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2011
-
负责人:Raju VS Rajala
-
依托单位:
COBRE: INSULIN RECEPTOR SIGNALING IN DIABETIC RETINOPATHY
-
批准号:7720534
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2008
-
负责人:Raju VS Rajala
-
依托单位:
COBRE: INSULIN RECEPTOR SIGNALING IN DIABETIC RETINOPATHY
-
批准号:7610500
-
项目类别:
-
资助金额:$7.26万
-
财政年份:2007
-
负责人:Raju VS Rajala
-
依托单位:
COBRE: INSULIN RECEPTOR SIGNALING IN RETINA
-
批准号:7381939
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:8526462
-
项目类别:
-
资助金额:$33.74万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:8323409
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:7257011
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:7145574
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:7985004
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:8128492
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
Light Activation of Retinal Insulin Receptor Signaling
-
批准号:7633165
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2006
-
负责人:Raju VS Rajala
-
依托单位:
COBRE: INSULIN RECEPTOR SIGNALING IN RETINA
-
批准号:7171159
-
项目类别:
-
资助金额:$16.93万
-
财政年份:2005
-
负责人:Raju VS Rajala
-
依托单位:
COBRE: INSULIN RECEPTOR SIGNALING IN RETINA
-
批准号:6982236
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2004
-
负责人:Raju VS Rajala
-
依托单位:
国内基金
海外基金
登录
查看更多内容
坡模酸通过抑制β-arrestin2介导的M2型巨噬细胞极化抗肝纤维化的机制研究
-
批准号:2026JJ81069
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱萱
-
依托单位:
电针刺激ST36通过DRD1/β-arrestin1信
号通路抑制炎症性骨丢失的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:刘冠峤
-
依托单位:
电针激活β-arrestin 1/IFN通路促进“冷-热”免疫表型转化协同IDO抑制剂治疗MSS肠癌的机制研究
-
批准号:
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:时佳琪
-
依托单位:
电针激活β-arrestin 1/IFN通路促进"冷-热"免疫表型转化协同IDO抑制剂治疗MSS肠癌的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:时佳琪
-
依托单位:
GRK3激活β-arrestin-网格蛋白促进EGFR内吞导致结直肠癌西妥昔单抗治疗耐药的机制研究
-
批准号:82303846
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李源
-
依托单位:
催产素系统通过β-arrestin2下调IL-25表达改善IBS-D肠道低度炎症的机制研究
-
批准号:82300613
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:于祎昂
-
依托单位:
CB2R-β-arrestin1抑制小胶质细胞代谢重编程调控神经炎症在改善POCD中的机制研究
-
批准号:82360227
-
项目类别:地区科学基金项目
-
资助金额:32.2万元
-
批准年份:2023
-
负责人:张列亮
-
依托单位:
L-dopa通过外泌体miRNA-301b靶向调控β-arrestin2下调激活D1R信号通路参与帕金森病异动症的机制研究
-
批准号:LZ23H090001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:谢成龙
-
依托单位:
GPR120通过β-Arrestin2介导糖尿病性ED阴茎海绵体内皮损伤修复机制的研究
-
批准号:82371633
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:林浩成
-
依托单位:
基于GPR43/β-arrestin2通路探讨八正散调节肠道菌群介导短链脂肪酸代谢抑制肾结石氧化应激反应的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位: